Actinium Pharmaceuticals SG&A Expense (TTM) Analysis

Actinium Pharmaceuticals Inc (ATNM)

6.96 -0.24 (-3.33%) USD | NYAM | Jul 02, 16:00

6.82 -0.14 (-2.01%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2007. Upgrade now.

Date	Value
March 31, 2024	12.56M
December 31, 2023	13.33M
September 30, 2023	14.98M
June 30, 2023	15.33M
March 31, 2023	14.00M
December 31, 2022	12.00M
September 30, 2022	10.70M
June 30, 2022	9.617M
March 31, 2022	8.094M
December 31, 2021	8.077M
September 30, 2021	7.218M
June 30, 2021	7.049M
March 31, 2021	6.493M
December 31, 2020	6.307M
September 30, 2020	5.771M
June 30, 2020	5.768M
March 31, 2020	5.69M
December 31, 2019	5.521M
September 30, 2019	5.553M
June 30, 2019	5.701M
March 31, 2019	6.208M
December 31, 2018	6.732M
September 30, 2018	7.022M
June 30, 2018	6.709M
March 31, 2018	7.867M

Date	Value
December 31, 2017	9.191M
September 30, 2017	10.26M
June 30, 2017	10.00M
March 31, 2017	10.01M
December 31, 2016	9.019M
September 30, 2016	8.487M
June 30, 2016	8.887M
March 31, 2016	9.686M
December 31, 2015	11.27M
September 30, 2015	11.60M
June 30, 2015	12.70M
March 31, 2015	11.43M
December 31, 2014	10.18M
September 30, 2014	8.469M
June 30, 2014	6.411M
March 31, 2014	5.091M
December 31, 2013	3.477M
September 30, 2013	5.716M
June 30, 2013	5.608M
March 31, 2013	4.879M
December 31, 2012	4.506M
September 30, 2012	4.471M
June 30, 2012	3.752M
March 31, 2012	3.517M
December 31, 2011	2.959M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

5.521M

Minimum

Dec 2019

15.33M

Maximum

Jun 2023

9.161M

Average

8.077M

Median

Dec 2021

SG&A Expense (TTM) Benchmarks